CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-23 | Stankovic Srdjan R. President | Grant or award · Stock Options (Right to Buy) | +72,463 | 72,463 | ||
| 2021-02-23 | Stankovic Srdjan R. President | Grant or award · Restricted Stock Units | +19,677 | 19,677 | ||
| 2021-02-23 | Kihara James Principal Accounting Officer | Grant or award · Stock Options (Right to Buy) | +6,187 | 6,187 | ||
| 2021-02-23 | Kihara James Principal Accounting Officer | Grant or award · Restricted Stock Units | +3,360 | 3,360 | ||
| 2021-02-23 | Ridloff Elena EVP and CFO | Grant or award · Stock Options (Right to Buy) | +36,231 | 36,231 | ||
| 2021-02-23 | Ridloff Elena EVP and CFO | Grant or award · Restricted Stock Units | +9,839 | 9,839 | ||
| 2021-02-23 | KIM AUSTIN D. EVP & General Counsel | Grant or award · Stock Options (Right to Buy) | +32,608 | 32,608 | ||
| 2021-02-23 | KIM AUSTIN D. EVP & General Counsel | Grant or award · Restricted Stock Units | +8,855 | 8,855 | ||
| 2021-02-23 | DAVIS STEPHEN CEO | Grant or award · Stock Options (Right to Buy) | +161,230 | 161,230 | ||
| 2021-02-23 | DAVIS STEPHEN CEO | Grant or award · Restricted Stock Units | +43,782 | 43,782 | ||
| 2021-02-04 | Ridloff Elena EVP and CFO | Grant or award | +6,490 | 10,391 | ||
| 2021-02-04 | Ridloff Elena EVP and CFO | Sale | −2,051 | $50.61 | $104K | 8,340 |
| 2021-02-04 | Stankovic Srdjan R. President | Grant or award | +19,231 | 39,478 | ||
| 2021-02-04 | Stankovic Srdjan R. President | Sale | −8,429 | $50.61 | $427K | 31,049 |
| 2021-02-04 | Stankovic Srdjan R. President | Grant or award · Employee Stock Option (Right to Buy) | +15,625 | 15,625 | ||
| 2021-02-04 | Stankovic Srdjan R. President | Grant or award · Employee Stock Option (Right to Buy) | +21,875 | 21,875 | ||
| 2021-02-04 | Stankovic Srdjan R. President | Grant or award · Employee Stock Option (Right to Buy) | +11,875 | 11,875 | ||
| 2021-02-04 | DAVIS STEPHEN CEO | Grant or award | +31,250 | 43,059 | ||
| 2021-02-04 | DAVIS STEPHEN CEO | Sale | −14,195 | $50.61 | $718K | 28,900 |
| 2021-02-04 | DAVIS STEPHEN CEO | Grant or award · Employee Stock Options (Right to Buy) | +40,625 | 40,625 |
Page 32 of 63 · 1,260 trades